The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition
Background Microseminoprotein-beta (MSP), a protein secreted by the prostate epithelium, may have a protective role in the development of prostate cancer. The only previous prospective study found a 2% reduced prostate cancer risk per unit increase in MSP. This work investigates the association of M...
Main Authors: | Smith Byrne, K, Appleby, PN, Key, TJ, Holmes, MV, Fensom, GK, Agudo, A, Ardanaz, E, Boeing, H, Bueno-de-Mesquita, HB, Chirlaque, MD, Kaaks, R, Larrañaga, N, Palli, D, Perez-Cornago, A, Quirós, JR, Ricceri, F, Sánchez, MJ, Tagliabue, G, Tsilidis, KK, Tumino, R, Fortner, RT, Ferrari, P, PRACTICAL Consortium, Riboli, E, Lilja, H, Travis, RC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2019
|
Similar Items
-
Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
by: Xu, X, et al.
Published: (2010) -
Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case–control sets from EPIC
by: Schmidt, J, et al.
Published: (2019) -
Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
by: Liisa Sjöblom, et al.
Published: (2016-01-01) -
β-Microseminoprotein binds CRISP-3 in human seminal plasma
by: Udby, L, et al.
Published: (2005) -
beta-Microseminoprotein binds CRISP-3 in human seminal plasma.
by: Udby, L, et al.
Published: (2005)